Literature DB >> 19421200

Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia.

M J Maisels1, J M Deridder, E A Kring, M Balasubramaniam.   

Abstract

OBJECTIVE: To evaluate predischarge transcutaneous bilirubin (TcB) measurements combined with risk factors as predictors of the risk of a subsequent total serum bilirubin (TSB) >or=17 mg per 100 ml (291 micromol l(-1)). STUDY
DESIGN: Routine TcB measurements are obtained daily for all infants in our well baby nursery. We performed a nested case-control study comparing all 75 infants who had been readmitted with TSB >or=17 mg per 100 ml (291 micromol l(-1)) between 1 February 2005 and 28 February 2007 with randomly selected controls that had not been readmitted. RESULT: Between 1 February 2005 and 28 February 2007, 11 456 infants were discharged from the well baby nursery. Seventy-five infants (0.65%) were readmitted at a mean age of 110+/-29.9 h with a TSB>or=17 mg per 100 ml (291 micromol l(-1)). All received phototherapy. Using logistic regression analysis, three variables were statistically significant for predicting cases: the maximum predischarge TcB percentile group (P<0.0001, adjusted odds ratio (AOR), >95th percentile 148; 95% confidence interval (CI) 21 to >999, AOR 76 to 95th percentile 15; 95% CI 3.1 to 70, AOR 50 to 75th percentile 6.1; 95% CI 1.3 to 28 compared with <50th percentile), exclusive breastfeeding (P<0.0001, AOR 11; 95% CI 3.7 to 34) and gestational age (P=0.0057, AOR 35 to 36 6/7 week 21; 95% CI 2.3 to 185, AOR 37 to 37 6/7 week 15; 95% CI 1.9 to 115, AOR 38 to 38 6/7 week 1.8; 95% CI 0.3 to 11, AOR 39 to 39 6/7 week 1.1; 95% CI 0.2 to 7 AOR >or=41 week 0.88; 95% CI 0.1 to 10 compared with 40 to 40 6/7 week infants). These three variables provided the best prediction of a case (c=0.885, area under the receiver operating characteristic curve) and this prediction was significantly better than the use of the clinical risk factors, gestation and exclusive breastfeeding, alone (c=0.770, P<0.001) or the TcB percentile grouping alone (c=0.766, P<0.001). Substituting the TcB rate of rise (c=0.903, P=0.316) or the last measured TcB (c=0.873, P=0.292) for the maximum TcB measurement did not significantly improve the predictors of a case.
CONCLUSION: Combining predischarge TcB levels with two clinical risk factors-gestational age and exclusive breastfeeding-significantly improves the prediction of subsequent hyperbilirubinemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421200     DOI: 10.1038/jp.2009.43

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  13 in total

1.  Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants.

Authors:  Zhang-Bin Yu; Xiao-Yue Dong; Shu-Ping Han; Yu-Lin Chen; Yu-Fang Qiu; Li Sha; Qing Sun; Xi-Rong Guo
Journal:  Eur J Pediatr       Date:  2010-09-03       Impact factor: 3.183

Review 2.  Managing the jaundiced newborn: a persistent challenge.

Authors:  M Jeffrey Maisels
Journal:  CMAJ       Date:  2014-11-10       Impact factor: 8.262

3.  Natural history of early neonatal bilirubinemia: a global perspective.

Authors:  Michael Kaplan; M Jeffrey Maisels
Journal:  J Perinatol       Date:  2021-01-04       Impact factor: 2.521

Review 4.  Bilirubin nomograms for identification of neonatal hyperbilirubinemia in healthy term and late-preterm infants: a systematic review and meta-analysis.

Authors:  Zhang-Bin Yu; Shu-Ping Han; Chao Chen
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

5.  Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.

Authors:  R Bromiker; A Goldberg; M Kaplan
Journal:  J Perinatol       Date:  2017-08-31       Impact factor: 2.521

6.  Accuracy of enhanced transcutaneous bilirubinometry according to various measurement sites.

Authors:  Lucia Casnocha Lucanova; Jana Zibolenova; Katarina Matasova; Lenka Docekalova; Mirko Zibolen
Journal:  Turk Arch Pediatr       Date:  2021-01-01

7.  Medical education content required for kernicterus risk recognition.

Authors:  Gláucia Macedo de Lima; Maria Amélia Sayeg Campos Porto; Antônio Ledo Alves da Cunha
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

8.  BiliCheck vs JM-103 in identifying neonates not at risk of hyperbilirubinaemia.

Authors:  Costantino Romagnoli; Piero Catenazzi; Giovanni Barone; Lucia Giordano; Riccardo Riccardi; Antonio Alberto Zuppa; Enrico Zecca
Journal:  Ital J Pediatr       Date:  2013-07-23       Impact factor: 2.638

9.  Transcutaneous bilirubin nomograms in African neonates.

Authors:  Bolajoko O Olusanya; Cecilia A Mabogunje; Donald O Imosemi; Abieyuwa A Emokpae
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

10.  Transcutaneous bilirubin measurement in healthy Saudi term newborns.

Authors:  Ghulam Nabi; Saad Alsaedi
Journal:  Saudi Med J       Date:  2016-07       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.